Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
New insights into COVID-19 infectiousness
Fri August 19th - British researchers have unveiled the first real-world study to estimate how long people are infectious with mild COVID-19. More
Gene variant that protects against heart disease
Fri August 19th - A gene variant has been identified that helps to protect against heart diseases. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Hepatocyte mutations linked to liver diseases

Thursday October 14th 2021

DNA mutations in liver cells lead to metabolism and insulin sensitivity in patients with liver disease, a new study has found.

The study, from the Wellcome Sanger Institute, the Cancer Research UK Cambridge Institute, the Cancer Grand Challenges Mutographs team, identified that the five mutations are specific to liver disease that is associated with obesity, type 2 diabetes, and chronic alcohol consumption.

Their findings provide a deeper understanding about the role three of them play in the disordered fat metabolism seen in non-alcoholic fatty liver disease (NAFLD) and chronic alcohol consumption.

The research, which is published in Nature, shows the mutations reduce the sensitivity of liver cells to insulin. Resistance to insulin activity is the hallmark of type 2 diabetes.

They say this demonstrates that acquired mutations could impair the liver’s ability to respond normally to dietary sugars and fats.

The new research analysed 1590 genomes from 34 patient liver samples, including healthy livers and those with liver disease. The team identified five hepatocytes that are mutated in patients who had liver disease, three of which have a direct impact on how liver cells metabolise fat and respond to insulin.

The identified cells that have mutations do not react to insulin signalling and do not take up the fats, which enables them to escape the damage caused by storing excess fat.

While the mutations are beneficial to the individual liver cell, they may impair its ability to contribute to the function of the liver as a whole.

Many of the patients had multiple independent mutations in metabolism genes and in some this led to mutations collectively impacting up to 15-25% of the entire liver.

The researchers found that the same metabolism gene was often recurrently mutated within an individual patient’s liver, but between different patients, the pattern of mutations was different.

This, they say, suggests it might be possible to split liver diseases into different subgroups defined by their patterns of mutations.

First author Dr Stanley Ng, postdoctoral fellow at the Wellcome Sanger Institute, said: “Liver disease is a complex disease that often sits at the centre of other issues and conditions such as obesity and type 2 diabetes. However, the relationship between these diseases is poorly understood.

“While further studies are needed to understand the genetic links between these conditions, and what the clinical consequences of the mutations are for our patients, our research leads to fascinating new understanding of systemic diseases and how to diagnose, manage, and treat them.”

Senior author Dr Matthew Hoare, advanced clinician scientist at the Cancer Research UK Cambridge Institute and member of the CRUK Cambridge Centre Early Detection Programme, added: “Understanding the role of these, and other, mutations in liver disease could help identify those who will be at higher risk of future complications, such as metabolic issues or liver cancer.

“Interestingly, none of the mutations in metabolism genes were linked to the development of liver cancer, possibly because cancer cells are hungry for nutrients and these mutations may actually disrupt the cells’ ability to meet those metabolic demands. This information may prove useful in understanding the changes experienced by a liver cancer as it evolves from a background of chronic liver disease.”

Tags: Cancer | Diabetes | Internal Medicine | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)